Chemicals

Showing 25201–25350 of 41137 results

  • Limaprost-d3 is intended for use as an internal standard for the quantification of limaprost (Item No. 13810) by GC- or LC-MS. Limaprost is an analog of prostaglandin E1 (PGE1; Item No. 13010) with structural modifications intended to give it a prolonged half-life and greater potency. Limaprost is orally active in both rats and guinea pigs at doses of 100 µg/kg as an inhibitor of ADP and collagen-induced platelet aggregation. Limaprost is 10-1,000 times more potent than PGE1 as an inhibitor of platelet adhesiveness measured in vitro. Intra-coronary injection (100 ng/kg) or intravenous injection (3 µg/kg) in anesthetized dogs causes vasodilation and increased coronary blood flow by 60-80%. Significant hypotensive effects were seen at 100 and 300 µg/kg orally in rats.{6808}  

     

    Brand:
    Cayman
    SKU:25416 - 500 µg

    Available on backorder

  • Limonin is the first described limonoid, which are naturally occurring tetranortriterpenoids that impart bitter flavor in citrus fruits. Compounds belonging to this group have reported anti-proliferative and proapoptotic activity on several cancer cell lines as well as pesticidal, anti-malarial, anti-microbial, and anti-HIV activity.{27612}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Limonin is the first described limonoid, which are naturally occurring tetranortriterpenoids that impart bitter flavor in citrus fruits. Compounds belonging to this group have reported anti-proliferative and proapoptotic activity on several cancer cell lines as well as pesticidal, anti-malarial, anti-microbial, and anti-HIV activity.{27612}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Limonin is the first described limonoid, which are naturally occurring tetranortriterpenoids that impart bitter flavor in citrus fruits. Compounds belonging to this group have reported anti-proliferative and proapoptotic activity on several cancer cell lines as well as pesticidal, anti-malarial, anti-microbial, and anti-HIV activity.{27612}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Limonin is the first described limonoid, which are naturally occurring tetranortriterpenoids that impart bitter flavor in citrus fruits. Compounds belonging to this group have reported anti-proliferative and proapoptotic activity on several cancer cell lines as well as pesticidal, anti-malarial, anti-microbial, and anti-HIV activity.{27612}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lin28 1632 is a small molecule inhibitor of the interaction between the RNA binding protein Lin28 and let-7 precursor RNA (IC50 = 8 μM in a competition ELISA).{41072} It increases levels of endogenous let-7 miRNAs and decreases Lin28 expression in a dose-dependent manner in murine embryonic stem cells (mESCs). Lin28 1632 inhibits clonogenic growth of 22Rv1, PC3, DU145, and Huh7 cancer cells and decreases tumor-sphere formation by 22Rv1 and Huh7 cells in vitro. It also binds bromodomain-containing protein 4 (BRD4) and CREB-binding protein (CBP/CREBBP) bromodomains (Kds = 7 and 25 μM, respectively).  

     

    Brand:
    Cayman
    SKU:22401 -

    Out of stock

  • Lin28 1632 is a small molecule inhibitor of the interaction between the RNA binding protein Lin28 and let-7 precursor RNA (IC50 = 8 μM in a competition ELISA).{41072} It increases levels of endogenous let-7 miRNAs and decreases Lin28 expression in a dose-dependent manner in murine embryonic stem cells (mESCs). Lin28 1632 inhibits clonogenic growth of 22Rv1, PC3, DU145, and Huh7 cancer cells and decreases tumor-sphere formation by 22Rv1 and Huh7 cells in vitro. It also binds bromodomain-containing protein 4 (BRD4) and CREB-binding protein (CBP/CREBBP) bromodomains (Kds = 7 and 25 μM, respectively).  

     

    Brand:
    Cayman
    SKU:22401 -

    Out of stock

  • Lin28 1632 is a small molecule inhibitor of the interaction between the RNA binding protein Lin28 and let-7 precursor RNA (IC50 = 8 μM in a competition ELISA).{41072} It increases levels of endogenous let-7 miRNAs and decreases Lin28 expression in a dose-dependent manner in murine embryonic stem cells (mESCs). Lin28 1632 inhibits clonogenic growth of 22Rv1, PC3, DU145, and Huh7 cancer cells and decreases tumor-sphere formation by 22Rv1 and Huh7 cells in vitro. It also binds bromodomain-containing protein 4 (BRD4) and CREB-binding protein (CBP/CREBBP) bromodomains (Kds = 7 and 25 μM, respectively).  

     

    Brand:
    Cayman
    SKU:22401 -

    Out of stock

  • Linaclotide is a peptide agonist of the guanylate cyclase C receptor (Ki = 16.4 nM in a radioligand binding assay using mouse intestinal mucosa).{40472} Luminal exposure to 5 μg of linaclotide stimulates fluid secretion and cGMP concentration in jejunal loops isolated from wild-type mice but not guanylate cyclase C receptor-null mice. Linaclotide (100 μg/kg) increases intestinal transit rate in wild-type mice. It also reduces the number of phosphorylated ERK-positive dorsal horn neurons in the thoracolumbar spinal cord, a marker of nociceptive signaling, following noxious colorectal distension and mechanical hypersensitivity in a mouse model of TNBS-induced colitis.{40473} Formulations containing linaclotide have been used for the treatment of constipation and pain associated with irritable bowel syndrome.  

     

    Brand:
    Cayman
    SKU:24085 - 1 mg

    Available on backorder

  • Linaclotide is a peptide agonist of the guanylate cyclase C receptor (Ki = 16.4 nM in a radioligand binding assay using mouse intestinal mucosa).{40472} Luminal exposure to 5 μg of linaclotide stimulates fluid secretion and cGMP concentration in jejunal loops isolated from wild-type mice but not guanylate cyclase C receptor-null mice. Linaclotide (100 μg/kg) increases intestinal transit rate in wild-type mice. It also reduces the number of phosphorylated ERK-positive dorsal horn neurons in the thoracolumbar spinal cord, a marker of nociceptive signaling, following noxious colorectal distension and mechanical hypersensitivity in a mouse model of TNBS-induced colitis.{40473} Formulations containing linaclotide have been used for the treatment of constipation and pain associated with irritable bowel syndrome.  

     

    Brand:
    Cayman
    SKU:24085 - 10 mg

    Available on backorder

  • Linaclotide is a peptide agonist of the guanylate cyclase C receptor (Ki = 16.4 nM in a radioligand binding assay using mouse intestinal mucosa).{40472} Luminal exposure to 5 μg of linaclotide stimulates fluid secretion and cGMP concentration in jejunal loops isolated from wild-type mice but not guanylate cyclase C receptor-null mice. Linaclotide (100 μg/kg) increases intestinal transit rate in wild-type mice. It also reduces the number of phosphorylated ERK-positive dorsal horn neurons in the thoracolumbar spinal cord, a marker of nociceptive signaling, following noxious colorectal distension and mechanical hypersensitivity in a mouse model of TNBS-induced colitis.{40473} Formulations containing linaclotide have been used for the treatment of constipation and pain associated with irritable bowel syndrome.  

     

    Brand:
    Cayman
    SKU:24085 - 5 mg

    Available on backorder

  • Linaclotide is a peptide agonist of the guanylate cyclase C receptor (Ki = 16.4 nM in a radioligand binding assay using mouse intestinal mucosa).{40472} Luminal exposure to 5 μg of linaclotide stimulates fluid secretion and cGMP concentration in jejunal loops isolated from wild-type mice but not guanylate cyclase C receptor-null mice. Linaclotide (100 μg/kg) increases intestinal transit rate in wild-type mice. It also reduces the number of phosphorylated ERK-positive dorsal horn neurons in the thoracolumbar spinal cord, a marker of nociceptive signaling, following noxious colorectal distension and mechanical hypersensitivity in a mouse model of TNBS-induced colitis.{40473} Formulations containing linaclotide have been used for the treatment of constipation and pain associated with irritable bowel syndrome.  

     

    Brand:
    Cayman
    SKU:24085 - 500 µg

    Available on backorder

  • Linagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4) with an IC50 value of 1 nM for human recombinant DPP-4.{41123} It is selective, with ≥10,000-fold selectivity for DPP-4 over a panel of 11 peptidases and proteases. Linagliptin (3 mg/kg) inhibits 90% of plasma DPP-4 activity in rat. It also dose-dependently decreases plasma glucose and increases plasma levels of glucagon-like peptide 1 (GLP-1) and insulin in Zucker diabetic fatty rats. Oral administration of linagliptin reduces HbA1c levels in mice with high-fat diet- and low-dose streptozotocin-induced diabetes.{41124} Formulations containing linagliptin have been used for the treatment of type 2 diabetes mellitus.{41125}  

     

    Brand:
    Cayman
    SKU:23306 - 1 g

    Available on backorder

  • Linagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4) with an IC50 value of 1 nM for human recombinant DPP-4.{41123} It is selective, with ≥10,000-fold selectivity for DPP-4 over a panel of 11 peptidases and proteases. Linagliptin (3 mg/kg) inhibits 90% of plasma DPP-4 activity in rat. It also dose-dependently decreases plasma glucose and increases plasma levels of glucagon-like peptide 1 (GLP-1) and insulin in Zucker diabetic fatty rats. Oral administration of linagliptin reduces HbA1c levels in mice with high-fat diet- and low-dose streptozotocin-induced diabetes.{41124} Formulations containing linagliptin have been used for the treatment of type 2 diabetes mellitus.{41125}  

     

    Brand:
    Cayman
    SKU:23306 - 100 mg

    Available on backorder

  • Linagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4) with an IC50 value of 1 nM for human recombinant DPP-4.{41123} It is selective, with ≥10,000-fold selectivity for DPP-4 over a panel of 11 peptidases and proteases. Linagliptin (3 mg/kg) inhibits 90% of plasma DPP-4 activity in rat. It also dose-dependently decreases plasma glucose and increases plasma levels of glucagon-like peptide 1 (GLP-1) and insulin in Zucker diabetic fatty rats. Oral administration of linagliptin reduces HbA1c levels in mice with high-fat diet- and low-dose streptozotocin-induced diabetes.{41124} Formulations containing linagliptin have been used for the treatment of type 2 diabetes mellitus.{41125}  

     

    Brand:
    Cayman
    SKU:23306 - 500 mg

    Available on backorder

  • Linamarin is a glucoside of acetone cyanohydrin found in the leaves and roots of cassava, lima beans, and flax.{32190} It is thought to function in the transport of nitrogen from plant leaves to roots in young plants but also serves as a plant defense mechanism. Linamarin is converted to toxic hydrocyanic acid or prussic acid when it comes into contact with linamarase, an enzyme that is released when the cells of cassava roots are ruptured.{32189}  

     

    Brand:
    Cayman
    SKU:20532 -

    Available on backorder

  • Linamarin is a glucoside of acetone cyanohydrin found in the leaves and roots of cassava, lima beans, and flax.{32190} It is thought to function in the transport of nitrogen from plant leaves to roots in young plants but also serves as a plant defense mechanism. Linamarin is converted to toxic hydrocyanic acid or prussic acid when it comes into contact with linamarase, an enzyme that is released when the cells of cassava roots are ruptured.{32189}  

     

    Brand:
    Cayman
    SKU:20532 -

    Available on backorder

  • Linamarin is a glucoside of acetone cyanohydrin found in the leaves and roots of cassava, lima beans, and flax.{32190} It is thought to function in the transport of nitrogen from plant leaves to roots in young plants but also serves as a plant defense mechanism. Linamarin is converted to toxic hydrocyanic acid or prussic acid when it comes into contact with linamarase, an enzyme that is released when the cells of cassava roots are ruptured.{32189}  

     

    Brand:
    Cayman
    SKU:20532 -

    Available on backorder

  • Linamarin is a glucoside of acetone cyanohydrin found in the leaves and roots of cassava, lima beans, and flax.{32190} It is thought to function in the transport of nitrogen from plant leaves to roots in young plants but also serves as a plant defense mechanism. Linamarin is converted to toxic hydrocyanic acid or prussic acid when it comes into contact with linamarase, an enzyme that is released when the cells of cassava roots are ruptured.{32189}  

     

    Brand:
    Cayman
    SKU:20532 -

    Available on backorder

  • Linarin is a flavonoid glycoside that has been found in various fruits and vegetables and has diverse biological activities.{45217,45218,45219} It potentiates cytotoxicity and apoptosis induced by tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in U87MG human glioma cells.{45217} In vivo, linarin potentiates TRAIL-induced tumor cell apoptosis and reduction of tumor growth in a U87MG mouse xenograft model. Linarin (12.5-50 mg/kg) reduces pulmonary platelet count, edema, and macrophage, polymorphonuclear leukocyte, and lymphocyte infiltration, as well as inhibits TXNIP/NLRP3, MAPK, and NF-κB signaling in a mouse model of LPS-induced acute lung injury.{45218} It also inhibits acetylcholinesterase (AChE) and induces dyskinesia recovery by 74.5 and 88%, respectively, in a zebrafish model of Alzheimer’s disease when administered in tank water at a concentration of 50 μg/ml.{45219}  

     

    Brand:
    Cayman
    SKU:26900 - 10 mg

    Available on backorder

  • Linarin is a flavonoid glycoside that has been found in various fruits and vegetables and has diverse biological activities.{45217,45218,45219} It potentiates cytotoxicity and apoptosis induced by tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in U87MG human glioma cells.{45217} In vivo, linarin potentiates TRAIL-induced tumor cell apoptosis and reduction of tumor growth in a U87MG mouse xenograft model. Linarin (12.5-50 mg/kg) reduces pulmonary platelet count, edema, and macrophage, polymorphonuclear leukocyte, and lymphocyte infiltration, as well as inhibits TXNIP/NLRP3, MAPK, and NF-κB signaling in a mouse model of LPS-induced acute lung injury.{45218} It also inhibits acetylcholinesterase (AChE) and induces dyskinesia recovery by 74.5 and 88%, respectively, in a zebrafish model of Alzheimer’s disease when administered in tank water at a concentration of 50 μg/ml.{45219}  

     

    Brand:
    Cayman
    SKU:26900 - 25 mg

    Available on backorder

  • Linarin is a flavonoid glycoside that has been found in various fruits and vegetables and has diverse biological activities.{45217,45218,45219} It potentiates cytotoxicity and apoptosis induced by tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in U87MG human glioma cells.{45217} In vivo, linarin potentiates TRAIL-induced tumor cell apoptosis and reduction of tumor growth in a U87MG mouse xenograft model. Linarin (12.5-50 mg/kg) reduces pulmonary platelet count, edema, and macrophage, polymorphonuclear leukocyte, and lymphocyte infiltration, as well as inhibits TXNIP/NLRP3, MAPK, and NF-κB signaling in a mouse model of LPS-induced acute lung injury.{45218} It also inhibits acetylcholinesterase (AChE) and induces dyskinesia recovery by 74.5 and 88%, respectively, in a zebrafish model of Alzheimer’s disease when administered in tank water at a concentration of 50 μg/ml.{45219}  

     

    Brand:
    Cayman
    SKU:26900 - 5 mg

    Available on backorder

  • Linarin is a flavonoid glycoside that has been found in various fruits and vegetables and has diverse biological activities.{45217,45218,45219} It potentiates cytotoxicity and apoptosis induced by tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in U87MG human glioma cells.{45217} In vivo, linarin potentiates TRAIL-induced tumor cell apoptosis and reduction of tumor growth in a U87MG mouse xenograft model. Linarin (12.5-50 mg/kg) reduces pulmonary platelet count, edema, and macrophage, polymorphonuclear leukocyte, and lymphocyte infiltration, as well as inhibits TXNIP/NLRP3, MAPK, and NF-κB signaling in a mouse model of LPS-induced acute lung injury.{45218} It also inhibits acetylcholinesterase (AChE) and induces dyskinesia recovery by 74.5 and 88%, respectively, in a zebrafish model of Alzheimer’s disease when administered in tank water at a concentration of 50 μg/ml.{45219}  

     

    Brand:
    Cayman
    SKU:26900 - 50 mg

    Available on backorder

  • Lincomycin is a lincosamide antibiotic first isolated from S. lincolnensis. It has a spectrum and mechanism of action similar to erythromycin (Item No. 16486), a macrolide antibiotic that inhibits bacterial protein synthesis and is effective against a host of bacterial genera, including Streptococcus, Staphylococcus, and Haemophilus (MIC90s range from 0.015-2.0 mg/l).{22680,22758} Lincomycin is closely related to clindamycin (Item No. 15006), a lincosamide antibiotic that is used for serious infections and in the prevention of emerging infections in burns.{22532,22529,22530,22528}  

     

    Brand:
    Cayman
    SKU:21526 -

    Out of stock

  • Lincomycin is a lincosamide antibiotic first isolated from S. lincolnensis. It has a spectrum and mechanism of action similar to erythromycin (Item No. 16486), a macrolide antibiotic that inhibits bacterial protein synthesis and is effective against a host of bacterial genera, including Streptococcus, Staphylococcus, and Haemophilus (MIC90s range from 0.015-2.0 mg/l).{22680,22758} Lincomycin is closely related to clindamycin (Item No. 15006), a lincosamide antibiotic that is used for serious infections and in the prevention of emerging infections in burns.{22532,22529,22530,22528}  

     

    Brand:
    Cayman
    SKU:21526 -

    Out of stock

  • Linderane is a sesquiterpene that has been found in L. aggregata.{45215,45216} It inhibits the cytochrome P450 (CYP) isoform CYP2C9 (Ki = 1.26 μM) in an irreversible and NADPH-dependent manner.{45215} Linderane decreases phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) gene expression, cAMP concentration, and CREB phosphorylation, increases phosphodiesterase 3 (PDE3) activity, and inhibits gluconeogenesis in rat primary hepatocytes.{45216} In vivo, linderane (50 mg/kg twice per day) decreases serum and hepatic triglyceride levels, as well as random-fed and fasting blood glucose levels in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:27479 - 10 mg

    Available on backorder

  • Linderane is a sesquiterpene that has been found in L. aggregata.{45215,45216} It inhibits the cytochrome P450 (CYP) isoform CYP2C9 (Ki = 1.26 μM) in an irreversible and NADPH-dependent manner.{45215} Linderane decreases phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) gene expression, cAMP concentration, and CREB phosphorylation, increases phosphodiesterase 3 (PDE3) activity, and inhibits gluconeogenesis in rat primary hepatocytes.{45216} In vivo, linderane (50 mg/kg twice per day) decreases serum and hepatic triglyceride levels, as well as random-fed and fasting blood glucose levels in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:27479 - 25 mg

    Available on backorder

  • Linderane is a sesquiterpene that has been found in L. aggregata.{45215,45216} It inhibits the cytochrome P450 (CYP) isoform CYP2C9 (Ki = 1.26 μM) in an irreversible and NADPH-dependent manner.{45215} Linderane decreases phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) gene expression, cAMP concentration, and CREB phosphorylation, increases phosphodiesterase 3 (PDE3) activity, and inhibits gluconeogenesis in rat primary hepatocytes.{45216} In vivo, linderane (50 mg/kg twice per day) decreases serum and hepatic triglyceride levels, as well as random-fed and fasting blood glucose levels in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:27479 - 5 mg

    Available on backorder

  • Linderane is a sesquiterpene that has been found in L. aggregata.{45215,45216} It inhibits the cytochrome P450 (CYP) isoform CYP2C9 (Ki = 1.26 μM) in an irreversible and NADPH-dependent manner.{45215} Linderane decreases phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) gene expression, cAMP concentration, and CREB phosphorylation, increases phosphodiesterase 3 (PDE3) activity, and inhibits gluconeogenesis in rat primary hepatocytes.{45216} In vivo, linderane (50 mg/kg twice per day) decreases serum and hepatic triglyceride levels, as well as random-fed and fasting blood glucose levels in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:27479 - 50 mg

    Available on backorder

  • Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:-
  • Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:-
  • Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:-
  • Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:-
  • Linezolid-d3 is intended for use as an internal standard for the quantification of linezolid (Item No. 15012) by GC- or LC-MS. Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:25038 - 1 mg

    Available on backorder

  • Linezolid-d3 is intended for use as an internal standard for the quantification of linezolid (Item No. 15012) by GC- or LC-MS. Linezolid is a synthetic oxazolidinone antibiotic with activity against a wide range of Gram-positive bacteria, including resistant strains of several species, such as methicillin-resistant S. aureus (MRSA), penicillin-resistant pneumococci, vancomycin-resistant enterococci, various anaerobic bacteria, and several mycobacteria and streptococci (MICs = 2-4 mg/ml).{22653} Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. In vivo, linezolid (50 mg/kg) reduces pulmonary MRSA load in spontaneously breathing and mechanically ventilated rabbits.{36681} Formulations containing linezolid have been used to treat MRSA infections.  

     

    Brand:
    Cayman
    SKU:25038 - 500 µg

    Available on backorder

  • Linoelaidic acid is the all-trans fatty acid homolog of linoleic acid. Trans-fatty acids are generally not detected in raw food oils, but constitute up to 25% of the unsaturated fat in partially hydrogenated oils.{5470}  

     

    Brand:
    Cayman
    SKU:90160 - 1 g

    Available on backorder

  • Linoelaidic acid is the all-trans fatty acid homolog of linoleic acid. Trans-fatty acids are generally not detected in raw food oils, but constitute up to 25% of the unsaturated fat in partially hydrogenated oils.{5470}  

     

    Brand:
    Cayman
    SKU:90160 - 100 mg

    Available on backorder

  • Linoelaidic acid is the all-trans fatty acid homolog of linoleic acid. Trans-fatty acids are generally not detected in raw food oils, but constitute up to 25% of the unsaturated fat in partially hydrogenated oils.{5470}  

     

    Brand:
    Cayman
    SKU:90160 - 250 mg

    Available on backorder

  • Linoelaidic acid is the all-trans fatty acid homolog of linoleic acid. Trans-fatty acids are generally not detected in raw food oils, but constitute up to 25% of the unsaturated fat in partially hydrogenated oils.{5470}  

     

    Brand:
    Cayman
    SKU:90160 - 5 g

    Available on backorder

  • Linoelaidic acid methyl ester is an esterified form of linoelaidic acid (Item No. 90160). It has been found in H. sabdariffa essential oil as well as biodiesel produced from sea mango seed oil.{49143,49144}  

     

    Brand:
    Cayman
    SKU:26732 - 100 mg

    Available on backorder

  • Linoelaidic acid methyl ester is an esterified form of linoelaidic acid (Item No. 90160). It has been found in H. sabdariffa essential oil as well as biodiesel produced from sea mango seed oil.{49143,49144}  

     

    Brand:
    Cayman
    SKU:26732 - 50 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:90150 - 1 g

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:90150 - 100 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:90150 - 50 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:90150 - 500 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128} Linoleic acid (peroxide free) contains the antioxidant BHT (Item No. 89910). BHT-free linoleic acid (Item Nos. 90150 | 21909) is also available.  

     

    Brand:
    Cayman
    SKU:90150.1 - 100 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128} Linoleic acid (peroxide free) contains the antioxidant BHT (Item No. 89910). BHT-free linoleic acid (Item Nos. 90150 | 21909) is also available.  

     

    Brand:
    Cayman
    SKU:90150.1 - 250 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128} Linoleic acid (peroxide free) contains the antioxidant BHT (Item No. 89910). BHT-free linoleic acid (Item Nos. 90150 | 21909) is also available.  

     

    Brand:
    Cayman
    SKU:90150.1 - 50 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128} Linoleic acid (peroxide free) contains the antioxidant BHT (Item No. 89910). BHT-free linoleic acid (Item Nos. 90150 | 21909) is also available.  

     

    Brand:
    Cayman
    SKU:90150.1 - 500 mg

    Available on backorder

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:21909 -

    Out of stock

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:21909 -

    Out of stock

  • Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:21909 -

    Out of stock

  • Linoleic acid alkyne is an ω-alkyne derivative of linoleic acid (Item No. 90150). The ω-alkyne moiety allows Cu(I)-catalyzed cycloaddition chemistry with other molecules containing an azide group.{33415,33416} Linoleic acid alkyne has been used in experiments focusing on the biological roles of linoleic acid.{26526,33418} Alternatively, this modified lipid can be used to synthesize other alkyne-containing products, such as glycerophospholipids, for click chemistry.{33417}  

     

    Brand:
    Cayman
    SKU:10541 - 1 mg

    Available on backorder

  • Linoleic acid alkyne is an ω-alkyne derivative of linoleic acid (Item No. 90150). The ω-alkyne moiety allows Cu(I)-catalyzed cycloaddition chemistry with other molecules containing an azide group.{33415,33416} Linoleic acid alkyne has been used in experiments focusing on the biological roles of linoleic acid.{26526,33418} Alternatively, this modified lipid can be used to synthesize other alkyne-containing products, such as glycerophospholipids, for click chemistry.{33417}  

     

    Brand:
    Cayman
    SKU:10541 - 100 µg

    Available on backorder

  • Linoleic acid alkyne is an ω-alkyne derivative of linoleic acid (Item No. 90150). The ω-alkyne moiety allows Cu(I)-catalyzed cycloaddition chemistry with other molecules containing an azide group.{33415,33416} Linoleic acid alkyne has been used in experiments focusing on the biological roles of linoleic acid.{26526,33418} Alternatively, this modified lipid can be used to synthesize other alkyne-containing products, such as glycerophospholipids, for click chemistry.{33417}  

     

    Brand:
    Cayman
    SKU:10541 - 5 mg

    Available on backorder

  • Linoleic acid alkyne is an ω-alkyne derivative of linoleic acid (Item No. 90150). The ω-alkyne moiety allows Cu(I)-catalyzed cycloaddition chemistry with other molecules containing an azide group.{33415,33416} Linoleic acid alkyne has been used in experiments focusing on the biological roles of linoleic acid.{26526,33418} Alternatively, this modified lipid can be used to synthesize other alkyne-containing products, such as glycerophospholipids, for click chemistry.{33417}  

     

    Brand:
    Cayman
    SKU:10541 - 500 µg

    Available on backorder

  • Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It is active against the bacteria S. mutans, A. actinomycetemcomitans, P. gingivalis, S. gordonii, and S. sanguis and the fungus C. albicans when used at a concentration of 25 µg/ml.{53851} Linoleic acid ethyl ester (5 and 10 µM) inhibits LPS-induced production of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), IL-6, and TNF-α in RAW 264.7 cells.{53852} Formulations containing linoleic acid ethyl ester have been used in cosmetics for the treatment of acne.  

     

    Brand:
    Cayman
    SKU:10008198 - 1 g

    Available on backorder

  • Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It is active against the bacteria S. mutans, A. actinomycetemcomitans, P. gingivalis, S. gordonii, and S. sanguis and the fungus C. albicans when used at a concentration of 25 µg/ml.{53851} Linoleic acid ethyl ester (5 and 10 µM) inhibits LPS-induced production of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), IL-6, and TNF-α in RAW 264.7 cells.{53852} Formulations containing linoleic acid ethyl ester have been used in cosmetics for the treatment of acne.  

     

    Brand:
    Cayman
    SKU:10008198 - 100 mg

    Available on backorder

  • Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It is active against the bacteria S. mutans, A. actinomycetemcomitans, P. gingivalis, S. gordonii, and S. sanguis and the fungus C. albicans when used at a concentration of 25 µg/ml.{53851} Linoleic acid ethyl ester (5 and 10 µM) inhibits LPS-induced production of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), IL-6, and TNF-α in RAW 264.7 cells.{53852} Formulations containing linoleic acid ethyl ester have been used in cosmetics for the treatment of acne.  

     

    Brand:
    Cayman
    SKU:10008198 - 50 mg

    Available on backorder

  • Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It is active against the bacteria S. mutans, A. actinomycetemcomitans, P. gingivalis, S. gordonii, and S. sanguis and the fungus C. albicans when used at a concentration of 25 µg/ml.{53851} Linoleic acid ethyl ester (5 and 10 µM) inhibits LPS-induced production of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), IL-6, and TNF-α in RAW 264.7 cells.{53852} Formulations containing linoleic acid ethyl ester have been used in cosmetics for the treatment of acne.  

     

    Brand:
    Cayman
    SKU:10008198 - 500 mg

    Available on backorder

  • Linoleic acid methyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It has been found in several types of animal fat biodiesel and biodiesel synthesized from beef tallow, soybean oil, and babassu oil blends.{48244,48265} It has been used as a substrate to measure the antioxidant activity of β-carotene (Item No. 16837) against free radical-induced lipid peroxidation.{56142}  

     

    Brand:
    Cayman
    SKU:20603 -

    Available on backorder

  • Linoleic acid methyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It has been found in several types of animal fat biodiesel and biodiesel synthesized from beef tallow, soybean oil, and babassu oil blends.{48244,48265} It has been used as a substrate to measure the antioxidant activity of β-carotene (Item No. 16837) against free radical-induced lipid peroxidation.{56142}  

     

    Brand:
    Cayman
    SKU:20603 -

    Available on backorder

  • Linoleic acid methyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). It has been found in several types of animal fat biodiesel and biodiesel synthesized from beef tallow, soybean oil, and babassu oil blends.{48244,48265} It has been used as a substrate to measure the antioxidant activity of β-carotene (Item No. 16837) against free radical-induced lipid peroxidation.{56142}  

     

    Brand:
    Cayman
    SKU:20603 -

    Available on backorder

  • Linoleic Acid-13C18 is intended for use as an internal standard for the quantification of linoleic acid (Item Nos. 90150 | 90150.1 | 21909) by GC- or LC-MS. Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:31159 - 1 mg

    Available on backorder

  • Linoleic Acid-13C18 is intended for use as an internal standard for the quantification of linoleic acid (Item Nos. 90150 | 90150.1 | 21909) by GC- or LC-MS. Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:31159 - 100 µg

    Available on backorder

  • Linoleic acid-13C18 ethyl ester is intended for use as an internal standard for the quantification of linoleic acid ethyl ester (Item No. 10008198) by GC- or LC-MS. Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). Linoleic acid is an essential fatty acid and one of the most abundant polyunsaturated fatty acids in the Western diet.{52085} Deficiencies in linoleic acid are linked to defective wound healing, growth retardation, and dermatitis.{1017,2418} Linoleic acid is metabolized in both plants and animals to form 9(S)- and 13(S)-HODE.{770}  

     

    Brand:
    Cayman
    SKU:28750 - 1 mg

    Available on backorder

  • Linoleic acid-13C18 ethyl ester is intended for use as an internal standard for the quantification of linoleic acid ethyl ester (Item No. 10008198) by GC- or LC-MS. Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). Linoleic acid is an essential fatty acid and one of the most abundant polyunsaturated fatty acids in the Western diet.{52085} Deficiencies in linoleic acid are linked to defective wound healing, growth retardation, and dermatitis.{1017,2418} Linoleic acid is metabolized in both plants and animals to form 9(S)- and 13(S)-HODE.{770}  

     

    Brand:
    Cayman
    SKU:28750 - 100 µg

    Available on backorder

  • Linoleic acid-13C18 ethyl ester is intended for use as an internal standard for the quantification of linoleic acid ethyl ester (Item No. 10008198) by GC- or LC-MS. Linoleic acid ethyl ester is an esterified form of linoleic acid (Item Nos. 90150 | 90150.1 | 21909). Linoleic acid is an essential fatty acid and one of the most abundant polyunsaturated fatty acids in the Western diet.{52085} Deficiencies in linoleic acid are linked to defective wound healing, growth retardation, and dermatitis.{1017,2418} Linoleic acid is metabolized in both plants and animals to form 9(S)- and 13(S)-HODE.{770}  

     

    Brand:
    Cayman
    SKU:28750 - 500 µg

    Available on backorder

  • Linoleic acid-d4 is intended for use as an internal standard for the quantification of linoleic acid (Item Nos. 90150 | 90150.1 | 21909) by GC- or LC-MS. Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:390150 - 1 mg

    Available on backorder

  • Linoleic acid-d4 is intended for use as an internal standard for the quantification of linoleic acid (Item Nos. 90150 | 90150.1 | 21909) by GC- or LC-MS. Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:390150 - 5 mg

    Available on backorder

  • Linoleic acid-d4 is intended for use as an internal standard for the quantification of linoleic acid (Item Nos. 90150 | 90150.1 | 21909) by GC- or LC-MS. Linoleic acid is an essential ω-6 polyunsaturated fatty acid (PUFA).{52085} It is the most abundant PUFA in a variety of foods, and dietary sources of linoleic acid include vegetable oils, meats, nuts, seeds, and eggs. Linoleic acid (30 μM) increases migration of IEC-6 rat intestinal epithelial cells in a wound healing assay.{56127} Rats fed a linoleate-deficient diet exhibit decreased body weight and an increased ratio of eicosatrienoate to arachidonate in liver and serum phospholipids compared with rats fed a control diet, as well as mild scaling of forepaw skin.{56128}  

     

    Brand:
    Cayman
    SKU:390150 - 500 µg

    Available on backorder

  • Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonyl ethanolamide (AEA).{11172,11151} It has weak affinity for the cannabinoid 1 (CB1) and CB2 receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5 fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:90155 - 10 mg

    Available on backorder

  • Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonyl ethanolamide (AEA).{11172,11151} It has weak affinity for the cannabinoid 1 (CB1) and CB2 receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5 fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:90155 - 100 mg

    Available on backorder

  • Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonyl ethanolamide (AEA).{11172,11151} It has weak affinity for the cannabinoid 1 (CB1) and CB2 receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5 fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:90155 - 5 mg

    Available on backorder

  • Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonyl ethanolamide (AEA).{11172,11151} It has weak affinity for the cannabinoid 1 (CB1) and CB2 receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5 fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:90155 - 50 mg

    Available on backorder

  • Linoleoyl ethanolamide phosphate is an intermediate in the biosynthesis of linoleoyl ethanolamide (Item No. 90155) that can be generated through phospholipase C-mediated hydrolysis of N-acylphosphatidylethanolamine.{24249} Linoleoyl ethanolamide phosphate, along with other endogenous N-acylethanolamines, is thought to play a role in the regulation of food intake by selective prolongation of feeding latency and post-meal interval.{24250}  

     

    Brand:
    Cayman
    SKU:9001837 - 1 mg

    Available on backorder

  • Linoleoyl ethanolamide phosphate is an intermediate in the biosynthesis of linoleoyl ethanolamide (Item No. 90155) that can be generated through phospholipase C-mediated hydrolysis of N-acylphosphatidylethanolamine.{24249} Linoleoyl ethanolamide phosphate, along with other endogenous N-acylethanolamines, is thought to play a role in the regulation of food intake by selective prolongation of feeding latency and post-meal interval.{24250}  

     

    Brand:
    Cayman
    SKU:9001837 - 5 mg

    Available on backorder

  • Linoleoyl ethanolamide phosphate is an intermediate in the biosynthesis of linoleoyl ethanolamide (Item No. 90155) that can be generated through phospholipase C-mediated hydrolysis of N-acylphosphatidylethanolamine.{24249} Linoleoyl ethanolamide phosphate, along with other endogenous N-acylethanolamines, is thought to play a role in the regulation of food intake by selective prolongation of feeding latency and post-meal interval.{24250}  

     

    Brand:
    Cayman
    SKU:9001837 - 500 µg

    Available on backorder

  • Linoleoyl ethanolamide-d4 contains four deuterium atoms at the hydroxyethyl 1,1′,2, and 2′ positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide (Item No. 90155) by GC- or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).{11172,11151} It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:9000553 - 1 mg

    Available on backorder

  • Linoleoyl ethanolamide-d4 contains four deuterium atoms at the hydroxyethyl 1,1′,2, and 2′ positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide (Item No. 90155) by GC- or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).{11172,11151} It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:9000553 - 100 µg

    Available on backorder

  • Linoleoyl ethanolamide-d4 contains four deuterium atoms at the hydroxyethyl 1,1′,2, and 2′ positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide (Item No. 90155) by GC- or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).{11172,11151} It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:9000553 - 5 mg

    Available on backorder

  • Linoleoyl ethanolamide-d4 contains four deuterium atoms at the hydroxyethyl 1,1′,2, and 2′ positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide (Item No. 90155) by GC- or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).{11172,11151} It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.{7422} However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).{11177} In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.{11152} However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.{7251,3922}  

     

    Brand:
    Cayman
    SKU:9000553 - 500 µg

    Available on backorder

  • N-Linoleoyl phenylalanine is an endogenous N-acyl amine found in D. melanogaster larvae.{33755} N-acyl amines have been shown to have anti-inflammatory action that can be monitored using 15-deoxy-prostaglandin J2 (PGJ2) quantification.{29259},{34731} N-Linoleoyl phenylalanine does not increase PGJ2 expression in RAW cells, indicating lack of an anti-inflammatory action.{34731} N-acyl amines also promote mitochondrial uncoupling.{31656}  

     

    Brand:
    Cayman
    SKU:20063 -

    Available on backorder

  • N-Linoleoyl phenylalanine is an endogenous N-acyl amine found in D. melanogaster larvae.{33755} N-acyl amines have been shown to have anti-inflammatory action that can be monitored using 15-deoxy-prostaglandin J2 (PGJ2) quantification.{29259},{34731} N-Linoleoyl phenylalanine does not increase PGJ2 expression in RAW cells, indicating lack of an anti-inflammatory action.{34731} N-acyl amines also promote mitochondrial uncoupling.{31656}  

     

    Brand:
    Cayman
    SKU:20063 -

    Available on backorder

  • N-Linoleoyl phenylalanine is an endogenous N-acyl amine found in D. melanogaster larvae.{33755} N-acyl amines have been shown to have anti-inflammatory action that can be monitored using 15-deoxy-prostaglandin J2 (PGJ2) quantification.{29259},{34731} N-Linoleoyl phenylalanine does not increase PGJ2 expression in RAW cells, indicating lack of an anti-inflammatory action.{34731} N-acyl amines also promote mitochondrial uncoupling.{31656}  

     

    Brand:
    Cayman
    SKU:20063 -

    Available on backorder

  • N-Linoleoyl phenylalanine is an endogenous N-acyl amine found in D. melanogaster larvae.{33755} N-acyl amines have been shown to have anti-inflammatory action that can be monitored using 15-deoxy-prostaglandin J2 (PGJ2) quantification.{29259},{34731} N-Linoleoyl phenylalanine does not increase PGJ2 expression in RAW cells, indicating lack of an anti-inflammatory action.{34731} N-acyl amines also promote mitochondrial uncoupling.{31656}  

     

    Brand:
    Cayman
    SKU:20063 -

    Available on backorder

  • Linoleoyl-L-carnitine is a naturally occurring long-chain acylcarnitine.{43657} Hepatic levels of linoleoyl-L-carnitine are increased following high-dose (200 mg/kg) administration of isoniazid (Item No. 20378) in mice.  

     

    Brand:
    Cayman
    SKU:26560 - 1 mg

    Available on backorder

  • Linoleoyl-L-carnitine is a naturally occurring long-chain acylcarnitine.{43657} Hepatic levels of linoleoyl-L-carnitine are increased following high-dose (200 mg/kg) administration of isoniazid (Item No. 20378) in mice.  

     

    Brand:
    Cayman
    SKU:26560 - 10 mg

    Available on backorder

  • Linoleoyl-L-carnitine is a naturally occurring long-chain acylcarnitine.{43657} Hepatic levels of linoleoyl-L-carnitine are increased following high-dose (200 mg/kg) administration of isoniazid (Item No. 20378) in mice.  

     

    Brand:
    Cayman
    SKU:26560 - 5 mg

    Available on backorder

  • Linoleoyl-L-carnitine is a naturally occurring long-chain acylcarnitine.{43657} Hepatic levels of linoleoyl-L-carnitine are increased following high-dose (200 mg/kg) administration of isoniazid (Item No. 20378) in mice.  

     

    Brand:
    Cayman
    SKU:26560 - 500 µg

    Available on backorder

  • Linopirdine is an enhancer of the stimulus-evoked but not basal release of several neurotransmitters, including acetylcholine, dopamine, serotonin, and glutamate. It increases acetylcholine release in rat hippocampal CA1 neurons by blocking voltage-gated, calcium-activated and leak (M-type; Kv7.2/7.3; KCNQ2/3) K+ current with an IC50 value of 2.4 µM.{31443,31441} Inhibition of M-channels is reported to result in the depolarization of CA3 pyramidal neurons and activated presynaptic voltage-gated P/Q- and N-type calcium channels, which leads to Ca2+ influx and increased neurotransmitter release.{31444} Linopirdine has been shown to produce a number of effects including EEG patterns of enhanced vigilance, induction of c-fos expression in cerebral cortex, reduction of the increase of cerebral glucose utilization induced by hypoxia, and improved performance in animal models of learning and memory.{31445} Linopirdine has also been identified as an agonist of transient receptor potential vanilloid type 1 (EC50 = 115 µM in HEK293 cells voltage clamped at -60 mV).{31442}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Linopirdine is an enhancer of the stimulus-evoked but not basal release of several neurotransmitters, including acetylcholine, dopamine, serotonin, and glutamate. It increases acetylcholine release in rat hippocampal CA1 neurons by blocking voltage-gated, calcium-activated and leak (M-type; Kv7.2/7.3; KCNQ2/3) K+ current with an IC50 value of 2.4 µM.{31443,31441} Inhibition of M-channels is reported to result in the depolarization of CA3 pyramidal neurons and activated presynaptic voltage-gated P/Q- and N-type calcium channels, which leads to Ca2+ influx and increased neurotransmitter release.{31444} Linopirdine has been shown to produce a number of effects including EEG patterns of enhanced vigilance, induction of c-fos expression in cerebral cortex, reduction of the increase of cerebral glucose utilization induced by hypoxia, and improved performance in animal models of learning and memory.{31445} Linopirdine has also been identified as an agonist of transient receptor potential vanilloid type 1 (EC50 = 115 µM in HEK293 cells voltage clamped at -60 mV).{31442}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Linopirdine is an enhancer of the stimulus-evoked but not basal release of several neurotransmitters, including acetylcholine, dopamine, serotonin, and glutamate. It increases acetylcholine release in rat hippocampal CA1 neurons by blocking voltage-gated, calcium-activated and leak (M-type; Kv7.2/7.3; KCNQ2/3) K+ current with an IC50 value of 2.4 µM.{31443,31441} Inhibition of M-channels is reported to result in the depolarization of CA3 pyramidal neurons and activated presynaptic voltage-gated P/Q- and N-type calcium channels, which leads to Ca2+ influx and increased neurotransmitter release.{31444} Linopirdine has been shown to produce a number of effects including EEG patterns of enhanced vigilance, induction of c-fos expression in cerebral cortex, reduction of the increase of cerebral glucose utilization induced by hypoxia, and improved performance in animal models of learning and memory.{31445} Linopirdine has also been identified as an agonist of transient receptor potential vanilloid type 1 (EC50 = 115 µM in HEK293 cells voltage clamped at -60 mV).{31442}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The binding of insulin-like growth factor 1 (IGF-1) to the IGF-1 receptor (IGF-1R) promotes cell growth while inhibiting apoptotic pathways. Overexpression of IGF-1R is found in certain solid tumors and hematologic neoplasias.{31137,31135} However, insulin receptor (InsR) signaling can compensate for IGF-1R inhibition.{31134} Linsitinib is a dual inhibitor of IGF-1R and InsR kinases (IC50s = 35 and 75 nM, respectively).{31136} It also inhibits InsR-related receptor (IC50 = 75 nM) but is without effect (IC50 > 10 µM) against a large panel of other kinases.{31136} Linsitinib inhibits proliferation of a variety of tumor cell lines in vitro and has antitumor efficacy in an IGF-1R-driven xenograft mouse model when administered orally.{31136} A rapid, non-invasive method to predict the pharmacodynamic response to linsitinib has been reported.{31134}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The binding of insulin-like growth factor 1 (IGF-1) to the IGF-1 receptor (IGF-1R) promotes cell growth while inhibiting apoptotic pathways. Overexpression of IGF-1R is found in certain solid tumors and hematologic neoplasias.{31137,31135} However, insulin receptor (InsR) signaling can compensate for IGF-1R inhibition.{31134} Linsitinib is a dual inhibitor of IGF-1R and InsR kinases (IC50s = 35 and 75 nM, respectively).{31136} It also inhibits InsR-related receptor (IC50 = 75 nM) but is without effect (IC50 > 10 µM) against a large panel of other kinases.{31136} Linsitinib inhibits proliferation of a variety of tumor cell lines in vitro and has antitumor efficacy in an IGF-1R-driven xenograft mouse model when administered orally.{31136} A rapid, non-invasive method to predict the pharmacodynamic response to linsitinib has been reported.{31134}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The binding of insulin-like growth factor 1 (IGF-1) to the IGF-1 receptor (IGF-1R) promotes cell growth while inhibiting apoptotic pathways. Overexpression of IGF-1R is found in certain solid tumors and hematologic neoplasias.{31137,31135} However, insulin receptor (InsR) signaling can compensate for IGF-1R inhibition.{31134} Linsitinib is a dual inhibitor of IGF-1R and InsR kinases (IC50s = 35 and 75 nM, respectively).{31136} It also inhibits InsR-related receptor (IC50 = 75 nM) but is without effect (IC50 > 10 µM) against a large panel of other kinases.{31136} Linsitinib inhibits proliferation of a variety of tumor cell lines in vitro and has antitumor efficacy in an IGF-1R-driven xenograft mouse model when administered orally.{31136} A rapid, non-invasive method to predict the pharmacodynamic response to linsitinib has been reported.{31134}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Lipofermata is an inhibitor of fatty acid transport (IC50 = 4.84 μM in Caco-2 cells).{36945} It inhibits uptake of long- and very long-chain, but not medium-chain, fatty acids in mmC2C12, rnINS-1E, Caco-2, and HepG2 cells (IC50s = 3-6 μM).{36946} Lipofermata inhibits induction of BiP and CHOP, apoptosis, and lipid droplet accumulation, as well as reduces production of reactive oxygen species (ROS) and reverses decreases in glutathione (GSH) levels induced by palmitate (Item No. 10010279) in HepG2 and INS-1E cells. In vivo, lipofermata (500 mg/kg) inhibits absorption of 13C-oleate in mice.  

     

    Brand:
    Cayman
    SKU:25869 - 10 mg

    Available on backorder

  • Lipofermata is an inhibitor of fatty acid transport (IC50 = 4.84 μM in Caco-2 cells).{36945} It inhibits uptake of long- and very long-chain, but not medium-chain, fatty acids in mmC2C12, rnINS-1E, Caco-2, and HepG2 cells (IC50s = 3-6 μM).{36946} Lipofermata inhibits induction of BiP and CHOP, apoptosis, and lipid droplet accumulation, as well as reduces production of reactive oxygen species (ROS) and reverses decreases in glutathione (GSH) levels induced by palmitate (Item No. 10010279) in HepG2 and INS-1E cells. In vivo, lipofermata (500 mg/kg) inhibits absorption of 13C-oleate in mice.  

     

    Brand:
    Cayman
    SKU:25869 - 25 mg

    Available on backorder

  • Lipofermata is an inhibitor of fatty acid transport (IC50 = 4.84 μM in Caco-2 cells).{36945} It inhibits uptake of long- and very long-chain, but not medium-chain, fatty acids in mmC2C12, rnINS-1E, Caco-2, and HepG2 cells (IC50s = 3-6 μM).{36946} Lipofermata inhibits induction of BiP and CHOP, apoptosis, and lipid droplet accumulation, as well as reduces production of reactive oxygen species (ROS) and reverses decreases in glutathione (GSH) levels induced by palmitate (Item No. 10010279) in HepG2 and INS-1E cells. In vivo, lipofermata (500 mg/kg) inhibits absorption of 13C-oleate in mice.  

     

    Brand:
    Cayman
    SKU:25869 - 5 mg

    Available on backorder

  • Lipofermata is an inhibitor of fatty acid transport (IC50 = 4.84 μM in Caco-2 cells).{36945} It inhibits uptake of long- and very long-chain, but not medium-chain, fatty acids in mmC2C12, rnINS-1E, Caco-2, and HepG2 cells (IC50s = 3-6 μM).{36946} Lipofermata inhibits induction of BiP and CHOP, apoptosis, and lipid droplet accumulation, as well as reduces production of reactive oxygen species (ROS) and reverses decreases in glutathione (GSH) levels induced by palmitate (Item No. 10010279) in HepG2 and INS-1E cells. In vivo, lipofermata (500 mg/kg) inhibits absorption of 13C-oleate in mice.  

     

    Brand:
    Cayman
    SKU:25869 - 50 mg

    Available on backorder

  • Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE (Item No. 34700) or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (Item No. 20110) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} Analytical and biological comparisons of synthetic LXA4 with endogenously derived LXA4 have confirmed its identity as matching the natural product.{14569}  

     

    Brand:
    Cayman
    SKU:90410 - 100 µg

    Available on backorder

  • Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE (Item No. 34700) or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (Item No. 20110) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} Analytical and biological comparisons of synthetic LXA4 with endogenously derived LXA4 have confirmed its identity as matching the natural product.{14569}  

     

    Brand:
    Cayman
    SKU:90410 - 25 µg

    Available on backorder

  • Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE (Item No. 34700) or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (Item No. 20110) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} Analytical and biological comparisons of synthetic LXA4 with endogenously derived LXA4 have confirmed its identity as matching the natural product.{14569}  

     

    Brand:
    Cayman
    SKU:90410 - 250 µg

    Available on backorder

  • Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE (Item No. 34700) or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (Item No. 20110) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} Analytical and biological comparisons of synthetic LXA4 with endogenously derived LXA4 have confirmed its identity as matching the natural product.{14569}  

     

    Brand:
    Cayman
    SKU:90410 - 50 µg

    Available on backorder

  • Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4; Item Nos. 10007240 | 20110) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} LXA4 MaxSpec® standard is a quantitative grade standard of LXA4 (Item No. 90410) that has been prepared specifically for mass spectrometry and related applications where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This LXA4 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007271 - 10 µg

    Available on backorder

  • Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10033 - 100 µg

    Available on backorder

  • Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10033 - 25 µg

    Available on backorder

  • Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10033 - 50 µg

    Available on backorder

  • Lipoxin A4-d5 (LXA4-d5) contains five deuterium atoms at the 19, 19’, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of LXA4 by GC- or LC-mass spectrometry (MS). LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10007737 - 10 µg

    Available on backorder

  • Lipoxin A4-d5 (LXA4-d5) contains five deuterium atoms at the 19, 19’, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of LXA4 by GC- or LC-mass spectrometry (MS). LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10007737 - 100 µg

    Available on backorder

  • Lipoxin A4-d5 (LXA4-d5) contains five deuterium atoms at the 19, 19’, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of LXA4 by GC- or LC-mass spectrometry (MS). LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10007737 - 25 µg

    Available on backorder

  • Lipoxin A4-d5 (LXA4-d5) contains five deuterium atoms at the 19, 19’, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of LXA4 by GC- or LC-mass spectrometry (MS). LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

     

    Brand:
    Cayman
    SKU:10007737 - 50 µg

    Available on backorder

  • Lipoxin A4-d5 (LXA4-d5) is intended for use as an internal standard for the quantification of LXA4 (Item Nos. 90410 | 10007271) by GC- or LC-mass spectrometry (MS). LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4; Item Nos. 20110 | 10007240) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722} LXA4-d5 MaxSpec® standard is a quantitative grade standard of LXA4-d5 (Item No. 10007737) that has been prepared specifically for mass spectrometry and related applications where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This LXA4-d5 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:24936 - 10 µg

    Available on backorder

  • Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.{15471} LXA5 slowly contracts pulmonary parenchymal strips from guinea pig with similar potency to that of LXA4 and LXB4.{15472} However, LXA5 does not exert the vasodilatory effects on aortic smooth muscle exhibited by LXA4 and LXB4.{15472}  

     

    Brand:
    Cayman
    SKU:10011453 - 100 µg

    Available on backorder

  • Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.{15471} LXA5 slowly contracts pulmonary parenchymal strips from guinea pig with similar potency to that of LXA4 and LXB4.{15472} However, LXA5 does not exert the vasodilatory effects on aortic smooth muscle exhibited by LXA4 and LXB4.{15472}  

     

    Brand:
    Cayman
    SKU:10011453 - 25 µg

    Available on backorder

  • Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.{15471} LXA5 slowly contracts pulmonary parenchymal strips from guinea pig with similar potency to that of LXA4 and LXB4.{15472} However, LXA5 does not exert the vasodilatory effects on aortic smooth muscle exhibited by LXA4 and LXB4.{15472}  

     

    Brand:
    Cayman
    SKU:10011453 - 50 µg

    Available on backorder

  • Lipoxin B4 (LXB4) is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15(S)-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:90420 - 100 µg

    Available on backorder

  • Lipoxin B4 (LXB4) is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15(S)-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:90420 - 25 µg

    Available on backorder

  • Lipoxin B4 (LXB4) is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15(S)-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:90420 - 50 µg

    Available on backorder

  • Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4 (Item No. 90420). LXB4 is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:24073 - 100 µg

    Available on backorder

  • Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4 (Item No. 90420). LXB4 is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:24073 - 25 µg

    Available on backorder

  • Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4 (Item No. 90420). LXB4 is a positional isomer of LXA4 (Item No. 90410) produced by the metabolism of 15-HETE (Item No. 34700) or 15-HpETE (Item No. 44720) by human leukocytes.{369,350} At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 (LTB4; Item No. 20110) and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM.{16457}  

     

    Brand:
    Cayman
    SKU:24073 - 50 µg

    Available on backorder

  • Lipoxygenin is an inhibitor of 5-lipoxygenase (5-LO) with an IC50 value of 5 µM for inhibition of 5-LO product synthesis in isolated human granulocytes stimulated with the cation ionophore A23187 (Item No. 22030).{48965} It inhibits hedgehog-dependent signaling in Shh-LIGHT2 cells and TGF-β-, activin A-, bone morphogenic protein (BMP)-, or Wnt-dependent signaling in HEK293T cells (IC50s = 9.3, 3.2, 8.2, 9.6, and 3.7 µM, respectively, in luciferase reporter assays). Lipoxygenin (5 and 10 µM) increases levels of troponin T (TnnT), a marker of cardiomyocyte differentiation, in human induced pluripotent stem cells (iPSCs) stimulated with BMP4 and the glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (Item No. 13122).  

     

    Brand:
    Cayman
    SKU:26310 - 1 mg

    Available on backorder

  • Lipoxygenin is an inhibitor of 5-lipoxygenase (5-LO) with an IC50 value of 5 µM for inhibition of 5-LO product synthesis in isolated human granulocytes stimulated with the cation ionophore A23187 (Item No. 22030).{48965} It inhibits hedgehog-dependent signaling in Shh-LIGHT2 cells and TGF-β-, activin A-, bone morphogenic protein (BMP)-, or Wnt-dependent signaling in HEK293T cells (IC50s = 9.3, 3.2, 8.2, 9.6, and 3.7 µM, respectively, in luciferase reporter assays). Lipoxygenin (5 and 10 µM) increases levels of troponin T (TnnT), a marker of cardiomyocyte differentiation, in human induced pluripotent stem cells (iPSCs) stimulated with BMP4 and the glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (Item No. 13122).  

     

    Brand:
    Cayman
    SKU:26310 - 10 mg

    Available on backorder

  • Lipoxygenin is an inhibitor of 5-lipoxygenase (5-LO) with an IC50 value of 5 µM for inhibition of 5-LO product synthesis in isolated human granulocytes stimulated with the cation ionophore A23187 (Item No. 22030).{48965} It inhibits hedgehog-dependent signaling in Shh-LIGHT2 cells and TGF-β-, activin A-, bone morphogenic protein (BMP)-, or Wnt-dependent signaling in HEK293T cells (IC50s = 9.3, 3.2, 8.2, 9.6, and 3.7 µM, respectively, in luciferase reporter assays). Lipoxygenin (5 and 10 µM) increases levels of troponin T (TnnT), a marker of cardiomyocyte differentiation, in human induced pluripotent stem cells (iPSCs) stimulated with BMP4 and the glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (Item No. 13122).  

     

    Brand:
    Cayman
    SKU:26310 - 5 mg

    Available on backorder

  • Liproxstatin-1 is a ferroptosis inhibitor.{28622} It inhibits ferroptotic cell death (IC50 = 22 nM) and lipid peroxidation in mouse embryonic fibroblasts (MEFs) with an inducible knockdown of glutathione peroxidase 4 (Gpx4-/- MEFs) when used at a concentration of 50 nM. Liproxstatin-1 also inhibits ferroptosis induced by the ferroptosis-inducing agents L-buthionine sulphoximine (BSO), erastin (Item No. 17754), and (1S,3R)-RSL3 (Item No. 19288) in a concentration-dependent manner in MEFs, but does not inhibit necroptosis, apoptosis, or necrosis. It inhibits cell death and lipid peroxidation induced by (1S,3R)-RSL3 in human renal proximal tubule epithelial cells. Liproxstatin-1 (10 mg/kg) increases survival and decreases TUNEL+ kidney cells in inducible Gpx4-/- mice and reduces tissue injury in a mouse model of hepatic ischemia/reperfusion injury. It is also an antioxidant that inhibits autooxidation of lipids by trapping peroxyl radicals.{43395}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Liproxstatin-1 is a ferroptosis inhibitor.{28622} It inhibits ferroptotic cell death (IC50 = 22 nM) and lipid peroxidation in mouse embryonic fibroblasts (MEFs) with an inducible knockdown of glutathione peroxidase 4 (Gpx4-/- MEFs) when used at a concentration of 50 nM. Liproxstatin-1 also inhibits ferroptosis induced by the ferroptosis-inducing agents L-buthionine sulphoximine (BSO), erastin (Item No. 17754), and (1S,3R)-RSL3 (Item No. 19288) in a concentration-dependent manner in MEFs, but does not inhibit necroptosis, apoptosis, or necrosis. It inhibits cell death and lipid peroxidation induced by (1S,3R)-RSL3 in human renal proximal tubule epithelial cells. Liproxstatin-1 (10 mg/kg) increases survival and decreases TUNEL+ kidney cells in inducible Gpx4-/- mice and reduces tissue injury in a mouse model of hepatic ischemia/reperfusion injury. It is also an antioxidant that inhibits autooxidation of lipids by trapping peroxyl radicals.{43395}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Liproxstatin-1 is a ferroptosis inhibitor.{28622} It inhibits ferroptotic cell death (IC50 = 22 nM) and lipid peroxidation in mouse embryonic fibroblasts (MEFs) with an inducible knockdown of glutathione peroxidase 4 (Gpx4-/- MEFs) when used at a concentration of 50 nM. Liproxstatin-1 also inhibits ferroptosis induced by the ferroptosis-inducing agents L-buthionine sulphoximine (BSO), erastin (Item No. 17754), and (1S,3R)-RSL3 (Item No. 19288) in a concentration-dependent manner in MEFs, but does not inhibit necroptosis, apoptosis, or necrosis. It inhibits cell death and lipid peroxidation induced by (1S,3R)-RSL3 in human renal proximal tubule epithelial cells. Liproxstatin-1 (10 mg/kg) increases survival and decreases TUNEL+ kidney cells in inducible Gpx4-/- mice and reduces tissue injury in a mouse model of hepatic ischemia/reperfusion injury. It is also an antioxidant that inhibits autooxidation of lipids by trapping peroxyl radicals.{43395}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Liproxstatin-1 is a ferroptosis inhibitor.{28622} It inhibits ferroptotic cell death (IC50 = 22 nM) and lipid peroxidation in mouse embryonic fibroblasts (MEFs) with an inducible knockdown of glutathione peroxidase 4 (Gpx4-/- MEFs) when used at a concentration of 50 nM. Liproxstatin-1 also inhibits ferroptosis induced by the ferroptosis-inducing agents L-buthionine sulphoximine (BSO), erastin (Item No. 17754), and (1S,3R)-RSL3 (Item No. 19288) in a concentration-dependent manner in MEFs, but does not inhibit necroptosis, apoptosis, or necrosis. It inhibits cell death and lipid peroxidation induced by (1S,3R)-RSL3 in human renal proximal tubule epithelial cells. Liproxstatin-1 (10 mg/kg) increases survival and decreases TUNEL+ kidney cells in inducible Gpx4-/- mice and reduces tissue injury in a mouse model of hepatic ischemia/reperfusion injury. It is also an antioxidant that inhibits autooxidation of lipids by trapping peroxyl radicals.{43395}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Liproxstatin-1 analog is an analog of the ferroptosis inhibitor liproxstatin-1 (Item No. 17730).  

     

    Brand:
    Cayman
    SKU:28591 - 1 mg

    Available on backorder

  • Liproxstatin-1 analog is an analog of the ferroptosis inhibitor liproxstatin-1 (Item No. 17730).  

     

    Brand:
    Cayman
    SKU:28591 - 10 mg

    Available on backorder

  • Liproxstatin-1 analog is an analog of the ferroptosis inhibitor liproxstatin-1 (Item No. 17730).  

     

    Brand:
    Cayman
    SKU:28591 - 5 mg

    Available on backorder

  • Liquiritin is a flavonoid that has been found in Glycyrrhiza and has diverse biological activities.{53639,53640,53641} It inhibits corticosterone-induced apoptosis in PC12 cells when used at concentrations of 1 and 2 mg/ml.{53639} Liquiritin (120 mg/kg) reduces spinal cord levels of IL-1β, IL-6, and TNF-α and alleviates mechanical and cold allodynia, as well as thermal hyperalgesia, in a mouse model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve.{53640} It decreases the viability of SiHa, CaSki, and HeLa cervical cancer cells and inhibits migration and invasion of SiHa cells in vitro when used at concentrations of 40, 60, and 80 μM.{53641} Liquiritin (10, 20, and 30 mg/kg) reduces tumor growth in a SiHa mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:30263 - 10 mg

    Available on backorder

  • Liquiritin is a flavonoid that has been found in Glycyrrhiza and has diverse biological activities.{53639,53640,53641} It inhibits corticosterone-induced apoptosis in PC12 cells when used at concentrations of 1 and 2 mg/ml.{53639} Liquiritin (120 mg/kg) reduces spinal cord levels of IL-1β, IL-6, and TNF-α and alleviates mechanical and cold allodynia, as well as thermal hyperalgesia, in a mouse model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve.{53640} It decreases the viability of SiHa, CaSki, and HeLa cervical cancer cells and inhibits migration and invasion of SiHa cells in vitro when used at concentrations of 40, 60, and 80 μM.{53641} Liquiritin (10, 20, and 30 mg/kg) reduces tumor growth in a SiHa mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:30263 - 25 mg

    Available on backorder

  • Liquiritin is a flavonoid that has been found in Glycyrrhiza and has diverse biological activities.{53639,53640,53641} It inhibits corticosterone-induced apoptosis in PC12 cells when used at concentrations of 1 and 2 mg/ml.{53639} Liquiritin (120 mg/kg) reduces spinal cord levels of IL-1β, IL-6, and TNF-α and alleviates mechanical and cold allodynia, as well as thermal hyperalgesia, in a mouse model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve.{53640} It decreases the viability of SiHa, CaSki, and HeLa cervical cancer cells and inhibits migration and invasion of SiHa cells in vitro when used at concentrations of 40, 60, and 80 μM.{53641} Liquiritin (10, 20, and 30 mg/kg) reduces tumor growth in a SiHa mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:30263 - 5 mg

    Available on backorder

  • Liquiritin is a flavonoid that has been found in Glycyrrhiza and has diverse biological activities.{53639,53640,53641} It inhibits corticosterone-induced apoptosis in PC12 cells when used at concentrations of 1 and 2 mg/ml.{53639} Liquiritin (120 mg/kg) reduces spinal cord levels of IL-1β, IL-6, and TNF-α and alleviates mechanical and cold allodynia, as well as thermal hyperalgesia, in a mouse model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve.{53640} It decreases the viability of SiHa, CaSki, and HeLa cervical cancer cells and inhibits migration and invasion of SiHa cells in vitro when used at concentrations of 40, 60, and 80 μM.{53641} Liquiritin (10, 20, and 30 mg/kg) reduces tumor growth in a SiHa mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:30263 - 50 mg

    Available on backorder

  • Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) (Item No. 24887) that contains a palmitic acid group.{43159} It increases cAMP accumulation in CHO cells expressing the human GLP-1 receptor (EC50 = 61 pM). Liraglutide (100-1,000 nM) inhibits cytokine- and free fatty acid-induced apoptosis of primary neonatal rat pancreatic β-cells in vitro by greater than 95 and 50%, respectively, effects that are blocked by the GLP-1 receptor antagonist exendin-3 (9-39) (Item No. 19890) and the PI3 kinase inhibitor wortmannin (Item No. 10010591).{43160} In a rat model of obesity induced by supplemental dietary candy, liraglutide (0.2 mg/kg, s.c., twice per day) decreases calorie intake, shifts food preference to a higher ratio of chow to candy, reverses weight and fat gains, and increases insulin sensitivity.{43161} Formulations containing liraglutide have been used as adjuncts in the treatment of type 2 diabetes and for chronic weight management in overweight or obese adults.  

     

    Brand:
    Cayman
    SKU:24727 - 1 mg

    Available on backorder

  • Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) (Item No. 24887) that contains a palmitic acid group.{43159} It increases cAMP accumulation in CHO cells expressing the human GLP-1 receptor (EC50 = 61 pM). Liraglutide (100-1,000 nM) inhibits cytokine- and free fatty acid-induced apoptosis of primary neonatal rat pancreatic β-cells in vitro by greater than 95 and 50%, respectively, effects that are blocked by the GLP-1 receptor antagonist exendin-3 (9-39) (Item No. 19890) and the PI3 kinase inhibitor wortmannin (Item No. 10010591).{43160} In a rat model of obesity induced by supplemental dietary candy, liraglutide (0.2 mg/kg, s.c., twice per day) decreases calorie intake, shifts food preference to a higher ratio of chow to candy, reverses weight and fat gains, and increases insulin sensitivity.{43161} Formulations containing liraglutide have been used as adjuncts in the treatment of type 2 diabetes and for chronic weight management in overweight or obese adults.  

     

    Brand:
    Cayman
    SKU:24727 - 5 mg

    Available on backorder

  • Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) (Item No. 24887) that contains a palmitic acid group.{43159} It increases cAMP accumulation in CHO cells expressing the human GLP-1 receptor (EC50 = 61 pM). Liraglutide (100-1,000 nM) inhibits cytokine- and free fatty acid-induced apoptosis of primary neonatal rat pancreatic β-cells in vitro by greater than 95 and 50%, respectively, effects that are blocked by the GLP-1 receptor antagonist exendin-3 (9-39) (Item No. 19890) and the PI3 kinase inhibitor wortmannin (Item No. 10010591).{43160} In a rat model of obesity induced by supplemental dietary candy, liraglutide (0.2 mg/kg, s.c., twice per day) decreases calorie intake, shifts food preference to a higher ratio of chow to candy, reverses weight and fat gains, and increases insulin sensitivity.{43161} Formulations containing liraglutide have been used as adjuncts in the treatment of type 2 diabetes and for chronic weight management in overweight or obese adults.  

     

    Brand:
    Cayman
    SKU:24727 - 500 µg

    Available on backorder

  • Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM).{16807} It reduces the formation of endothelin-1 (Item No. 24127) and increases nitric oxide (NO) in human vascular endothelial cells when used at a concentration of 0.1 nM.{16847} Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 µg/kg, respectively).{16807}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM).{16807} It reduces the formation of endothelin-1 (Item No. 24127) and increases nitric oxide (NO) in human vascular endothelial cells when used at a concentration of 0.1 nM.{16847} Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 µg/kg, respectively).{16807}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM).{16807} It reduces the formation of endothelin-1 (Item No. 24127) and increases nitric oxide (NO) in human vascular endothelial cells when used at a concentration of 0.1 nM.{16847} Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 µg/kg, respectively).{16807}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM).{16807} It reduces the formation of endothelin-1 (Item No. 24127) and increases nitric oxide (NO) in human vascular endothelial cells when used at a concentration of 0.1 nM.{16847} Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 µg/kg, respectively).{16807}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lisinopril-d5 is intended for use as an internal standard for the quantification of lisinopril (Item No. 16833) by GC- or LC-MS. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM).{16807} It reduces the formation of endothelin-1 and increases nitric oxide in human vascular endothelial cells.{16847} Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 µg/kg in rat and dog, respectively).{16807}  

     

    Brand:
    Cayman
    SKU:28520 - 1 mg

    Available on backorder

  • LIT-927 is an orally bioavailable neutraligand that binds to chemokine (C-X-C motif) ligand 12 (CXCL12; Ki = 267 nM in a FRET-based binding assay).{50130} It is selective for inhibiting calcium accumulation induced by CXCL12 over that induced by chemokine (C-C motif) ligand 17 (CCL17), CCL22, CCL5, and CCL2 at 10 µM. It inhibits pulmonary artery smooth muscle cell and pericyte migration in vitro.{52003} LIT-927 (100 mg/kg per day) inhibits increases in serum levels of CXCL12, as well as reduces total pulmonary vascular resistance and remodeling of pulmonary arterioles, in a rat model of pulmonary hypertension induced by monocrotaline (Item No. 16666). It inhibits allergen-induced eosinophil infiltration into the lung by 62% in a mouse model of allergic airway hypereosinophilia when administered at an oral dose of 1,400 µmol/kg.  

     

    Brand:
    Cayman
    SKU:28436 - 10 mg

    Available on backorder

  • LIT-927 is an orally bioavailable neutraligand that binds to chemokine (C-X-C motif) ligand 12 (CXCL12; Ki = 267 nM in a FRET-based binding assay).{50130} It is selective for inhibiting calcium accumulation induced by CXCL12 over that induced by chemokine (C-C motif) ligand 17 (CCL17), CCL22, CCL5, and CCL2 at 10 µM. It inhibits pulmonary artery smooth muscle cell and pericyte migration in vitro.{52003} LIT-927 (100 mg/kg per day) inhibits increases in serum levels of CXCL12, as well as reduces total pulmonary vascular resistance and remodeling of pulmonary arterioles, in a rat model of pulmonary hypertension induced by monocrotaline (Item No. 16666). It inhibits allergen-induced eosinophil infiltration into the lung by 62% in a mouse model of allergic airway hypereosinophilia when administered at an oral dose of 1,400 µmol/kg.  

     

    Brand:
    Cayman
    SKU:28436 - 25 mg

    Available on backorder

  • LIT-927 is an orally bioavailable neutraligand that binds to chemokine (C-X-C motif) ligand 12 (CXCL12; Ki = 267 nM in a FRET-based binding assay).{50130} It is selective for inhibiting calcium accumulation induced by CXCL12 over that induced by chemokine (C-C motif) ligand 17 (CCL17), CCL22, CCL5, and CCL2 at 10 µM. It inhibits pulmonary artery smooth muscle cell and pericyte migration in vitro.{52003} LIT-927 (100 mg/kg per day) inhibits increases in serum levels of CXCL12, as well as reduces total pulmonary vascular resistance and remodeling of pulmonary arterioles, in a rat model of pulmonary hypertension induced by monocrotaline (Item No. 16666). It inhibits allergen-induced eosinophil infiltration into the lung by 62% in a mouse model of allergic airway hypereosinophilia when administered at an oral dose of 1,400 µmol/kg.  

     

    Brand:
    Cayman
    SKU:28436 - 5 mg

    Available on backorder

  • LIT-927 is an orally bioavailable neutraligand that binds to chemokine (C-X-C motif) ligand 12 (CXCL12; Ki = 267 nM in a FRET-based binding assay).{50130} It is selective for inhibiting calcium accumulation induced by CXCL12 over that induced by chemokine (C-C motif) ligand 17 (CCL17), CCL22, CCL5, and CCL2 at 10 µM. It inhibits pulmonary artery smooth muscle cell and pericyte migration in vitro.{52003} LIT-927 (100 mg/kg per day) inhibits increases in serum levels of CXCL12, as well as reduces total pulmonary vascular resistance and remodeling of pulmonary arterioles, in a rat model of pulmonary hypertension induced by monocrotaline (Item No. 16666). It inhibits allergen-induced eosinophil infiltration into the lung by 62% in a mouse model of allergic airway hypereosinophilia when administered at an oral dose of 1,400 µmol/kg.  

     

    Brand:
    Cayman
    SKU:28436 - 50 mg

    Available on backorder

  • Lithocholic acid is a secondary bile acid that has been shown to cause cholestasis in animal models and has also been implicated in carcinogenesis.{32395,10150} It is produced from chenodeoxycholic acid by bacterial action in the colon and can be conjugated with glycine or taurine. Whereas in normal colonic epithelium lithocholic acid promotes apoptosis, it has been shown to suppress apoptosis in pre-malignant colonic epithelium in the presence of a carcinogen.{32394} Lithocholic acid can activate the pregnane X receptor and the vitamin D receptor, which may serve as a biological sensor to regulate lithocholic acid-induced toxicity.{10150,32396,16793}  

     

    Brand:
    Cayman
    SKU:20253 -

    Available on backorder

  • Lithocholic acid is a secondary bile acid that has been shown to cause cholestasis in animal models and has also been implicated in carcinogenesis.{32395,10150} It is produced from chenodeoxycholic acid by bacterial action in the colon and can be conjugated with glycine or taurine. Whereas in normal colonic epithelium lithocholic acid promotes apoptosis, it has been shown to suppress apoptosis in pre-malignant colonic epithelium in the presence of a carcinogen.{32394} Lithocholic acid can activate the pregnane X receptor and the vitamin D receptor, which may serve as a biological sensor to regulate lithocholic acid-induced toxicity.{10150,32396,16793}  

     

    Brand:
    Cayman
    SKU:20253 -

    Available on backorder